| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/2001 | WO2001022090A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | WO2001022078A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 03/29/2001 | WO2001021831A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | WO2001021762A2 Method of decreasing cholesterol uptake |
| 03/29/2001 | WO2001021663A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021651A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | WO2001021642A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 03/29/2001 | WO2001021634A1 Benzimidazole derivatives and combinatorial libraries thereof |
| 03/29/2001 | WO2001021623A1 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof |
| 03/29/2001 | WO2001021620A2 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines |
| 03/29/2001 | WO2001021619A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 03/29/2001 | WO2001021614A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 03/29/2001 | WO2001021610A1 Benzopyran derivative |
| 03/29/2001 | WO2001021605A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food |
| 03/29/2001 | WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp) |
| 03/29/2001 | WO2001021602A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 03/29/2001 | WO2001021600A1 Caspase inhibitor |
| 03/29/2001 | WO2001021598A1 Therapeutic quinazoline compounds |
| 03/29/2001 | WO2001021597A1 Therapeutic quinazoline derivatives |
| 03/29/2001 | WO2001021596A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/29/2001 | WO2001021595A1 Quinazoline derivatives |
| 03/29/2001 | WO2001021594A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 03/29/2001 | WO2001021593A1 New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 03/29/2001 | WO2001021591A1 Pyrazole derivatives |
| 03/29/2001 | WO2001021590A1 Muscarinic antagonists |
| 03/29/2001 | WO2001021589A2 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 03/29/2001 | WO2001021587A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 03/29/2001 | WO2001021585A2 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 03/29/2001 | WO2001021582A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 03/29/2001 | WO2001021575A1 Anti-inflammatory nitro- and thia- fatty acids |
| 03/29/2001 | WO2001021574A1 Systems and methods for opening obstructed biological conduits |
| 03/29/2001 | WO2001021259A2 Use and compositions for treating platelet-related disorders using anagrelide |
| 03/29/2001 | WO2001021233A1 High citrate dialysate and uses thereof |
| 03/29/2001 | WO2001021220A2 Bioprosthetic heart valves |
| 03/29/2001 | WO2001021216A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | WO2001021212A1 A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes |
| 03/29/2001 | WO2001021209A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 03/29/2001 | WO2001021206A1 PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT |
| 03/29/2001 | WO2001021195A1 Composition and method for treating burns |
| 03/29/2001 | WO2001021194A2 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 03/29/2001 | WO2001021190A1 Treatment for narcolepsy |
| 03/29/2001 | WO2001021186A1 Compositions inhibiting muscle atrophy |
| 03/29/2001 | WO2001021185A1 Novel pharmacological activities of curcuma longa extracts |
| 03/29/2001 | WO2001021182A1 Physical strength enhancing agents and glycogen accumulation promoting agents |
| 03/29/2001 | WO2001021181A1 PPARα AND PPARη INHIBITORS |
| 03/29/2001 | WO2001021180A1 Thrombopoietin mimetics |
| 03/29/2001 | WO2001021179A1 Quetiapine granules |
| 03/29/2001 | WO2001021178A2 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs |
| 03/29/2001 | WO2001021177A1 Chemokine/cytokine expression inhibitors |
| 03/29/2001 | WO2001021176A1 Methods of use of fluoroquinolone compounds against bacteria |
| 03/29/2001 | WO2001021175A1 Antibacterial medicinal compositions |
| 03/29/2001 | WO2001021174A1 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 03/29/2001 | WO2001021173A1 Novel uses of 2-bromopalmitate |
| 03/29/2001 | WO2001021172A1 Anti-cancer nitro- and thia-fatty acids |
| 03/29/2001 | WO2001021171A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021170A1 Systems for delivering anti-infective compositions from frangible ampules to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021169A1 Mch antagonists |
| 03/29/2001 | WO2001021168A1 A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| 03/29/2001 | WO2001021167A1 Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
| 03/29/2001 | WO2001021166A1 Treatment and prevention of hepatic disorders |
| 03/29/2001 | WO2001021165A1 Resveratrol analogs for prevention of disease |
| 03/29/2001 | WO2001021164A2 Anti-mycobacterium compositions and methods of preparing and using same |
| 03/29/2001 | WO2001021163A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/29/2001 | WO2001021162A2 Treating allergic and inflammatory conditions using desloratadine |
| 03/29/2001 | WO2001021161A2 Use of desloratadine for treating allergic and inflammatory conditions |
| 03/29/2001 | WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 03/29/2001 | WO2001021159A2 Pharmaceutical composition of nateglinide and another antidiabetcagent |
| 03/29/2001 | WO2001021157A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 03/29/2001 | WO2001021154A2 Surface modified particulate compositions of biologically active substances |
| 03/29/2001 | WO2001021153A2 Pharmaceutical gel containing active substances |
| 03/29/2001 | WO2001021148A1 No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
| 03/29/2001 | WO2001021137A1 Extracts of orange peel for prevention and treatment of cancer |
| 03/29/2001 | WO2001021135A2 Polymer conjugates of ara-c and ara-c derivatives |
| 03/29/2001 | WO2001021008A2 Method for increasing pet activity |
| 03/29/2001 | WO2001020992A1 Use of anti-inflammatory drugs for treatment of dermatological conditions |
| 03/29/2001 | WO2001020991A1 Phytochemicals for promoting weight loss |
| 03/29/2001 | WO2001020990A1 Phytochemicals for treatment of mastalgia and endometriosis |
| 03/29/2001 | WO2001020981A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 03/29/2001 | WO2001020969A2 Use of ribose to prevent cramping and soreness in muscles |
| 03/29/2001 | WO2001007067A3 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 03/29/2001 | WO2001007049A3 Ophthalmic composition comprising ketotifen |
| 03/29/2001 | WO2001007039A3 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases |
| 03/29/2001 | WO2001007024A3 Paracetamol and drotaverine containing composition |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2001001923A3 Composition based on fluorinated polymer and alpha-hydroxy-acid salt for topical use for skin protection |
| 03/29/2001 | WO2001000612A3 Respiratory syncytial virus replication inhibitors |
| 03/29/2001 | WO2000078294A3 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | WO2000073294A3 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 03/29/2001 | WO2000061742A3 Treatment of cardiac power failure using s100 proteins |
| 03/29/2001 | WO2000061233A3 Methods and compositions for the treatment and prevention of lung disease involving a specific rar-gamma agonist |
| 03/29/2001 | WO2000061232A3 Methods and compositions for the treatment and prevention of lung disease involving a specific rar-beta antagonist |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/29/2001 | WO2000054761A3 Regulation of phospholipase d activity |